The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (12): 1725-1730.doi: 10.3969/j.issn.1006-5725.2024.12.019
• Medical Examination and Clinical Diagnosis • Previous Articles Next Articles
Lichuang HUANG1,Liangyan JIANG1,Bixia ZHANG1,Shaolei WU2,Juntao HU1,Zhanhong TANG1()
Received:
2024-01-22
Online:
2024-06-25
Published:
2024-06-14
Contact:
Zhanhong TANG
E-mail:tangzhanhong139@sina.com
CLC Number:
Lichuang HUANG,Liangyan JIANG,Bixia ZHANG,Shaolei WU,Juntao HU,Zhanhong TANG. Interferon-γ Correlation with the severity of septic shock in patients and its prognostic value[J]. The Journal of Practical Medicine, 2024, 40(12): 1725-1730.
Tab.1
Clinical baseline data of the two groups of patients"
指标 | 生存组(n = 54) | 28 d死亡组(n = 42) | t/Z/χ2值 | P值 |
---|---|---|---|---|
性别[例(%)] | 80.762 | 0.01 | ||
男 | 44(81.48) | 36(85.71) | ||
女 | 10(18.52) | 6(14.29) | ||
年龄(岁) | 56(47,65) | 55(48,65) | -0.240 | 0.81 |
吸烟史[例(%)] | 26(48.15) | 11(26.19) | 4.809 | 0.028 |
饮酒史[例(%)] | 27(50.00) | 19(45.24) | 0.215 | 0.643 |
高血压[例(%)] | 19(35.19) | 9(21.43) | 2.164 | 0.141 |
糖尿病[例(%)] | 9(16.67) | 11(26.19) | 1.299 | 0.254 |
感染部位[例(%)] | ||||
肺部 | 24(44.44) | 18(42.86) | ||
腹部 | 22(40.74) | 17(40.48) | ||
其他 | 8(14.82) | 7(18.66) | ||
生命体征 | ||||
体温(x ± s,℃) | 37.13 ± 0.83 | 37.38 ± 1.03 | -1.332 | 0.186 |
心率(x ± s,次/min) | 110.69 ± 17.44 | 112.52 ± 21.27 | -0.456 | 0.64 |
SBP(mmHg) | 84(81,87) | 81(80,82) | -5.789 | 0.01 |
DBP(mmHg) | 52(50,55) | 51(47,52) | -2.656 | 0.01 |
SI(x ± s) | 1.30 ± 0.19 | 1.40 ± 0.27 | -2.150 | 0.03 |
24 h尿量(mL) | 1 875(875,3 213) | 1 025(108,2 188) | -1.921 | 0.055 |
WBC(× 109/L) | 12.18(6.91,17.45) | 12.17(7.75,17.57) | -0.244 | 0.807 |
PLT(x ± s,× 109/L) | 193.27 ± 152.88 | 151.72 ± 109.31 | 1.489 | 0.14 |
Hb(x ± s,g/L) | 89.37 ± 20.9 | 82.68 ± 23.91 | 1.461 | 0.147 |
Alb( g/L) | 30.65(28.78,33.63) | 29.95(26.95,33.13) | -0.960 | 0.337 |
ALT (U/L) | 23.0(12.5,41.5) | 30.5(14.8,136.5) | -1.585 | 0.113 |
TBIL(μmol/L) | 15.15(7.98,26.33) | 25.7(10.88,57.48) | -1.957 | 0.5 |
SCr(μmol/L) | 106(59,192) | 127(77,215) | -0.916 | 0.36 |
PaO2/O2(mmHg) | 194.5(107.8,244.8) | 180.0(105.5,258.8) | -0.343 | 0.731 |
Lac(mmol/L) | 2.4(2.1,2.8) | 5.0(2.9,8.0) | -5.713 | 0.01 |
IL-6(pg/ml) | 102.5(39.4,215.8) | 427.5(187.0,1 220.5) | -4.450 | 0.01 |
IFN-γ(ng/L) | 253.40(199.85,262.33) | 145.15(151.13,214.30) | -6.180 | 0.01 |
PCT(ng/ml) | 3.09(1.05,9.03) | 10.86(2.99,39.10) | -2.990 | 0.01 |
SOFA(分) | 11.0(8.8,12.0) | 13.5(13.0,16.3) | -6.730 | 0.01 |
APACHEⅡ(分) | 24(23,25) | 27(25,28) | -5.640 | 0.01 |
Tab.2
Multifactor logistic regression analysis affecting the prognosis of septic shock"
危险因素 | β | SE | Wald χ2 | P值 | OR | 95%CI |
---|---|---|---|---|---|---|
SBP | -0.417 | 0.325 | 1.652 | 0.199 | 0.659 | 0.349 ~ 1.245 |
DBP | 0.031 | 0.274 | 0.013 | 0.909 | 1.032 | 0.603 ~ 1.766 |
SI | -0.095 | 3.277 | 0.001 | 0.977 | 0.910 | 0.001 ~ 560.120 |
Lac | 1.870 | 0.781 | 5.735 | 0.017 | 6.491 | 1.404 ~ 30.004 |
IL-6 | -0.001 | 0.002 | 0.001 | 0.989 | 1.000 | 0.996 ~ 1.004 |
IFN-γ | -0.024 | 0.012 | 4.026 | 0.045 | 0.976 | 0.954 ~ 0.999 |
APACHEⅡ | 1.246 | 0.538 | 5.357 | 0.021 | 3.476 | 1.210 ~ 9.984 |
PCT | 0.017 | 0.040 | 0.178 | 0.673 | 1.017 | 0.940 ~ 1.101 |
SOFA | 0.546 | 0.350 | 2.439 | 0.118 | 1.727 | 0.870 ~ 3.427 |
1 |
NUNNALLY M E, FERRER R, MARTIN G S, et al. The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis [J]. Intensive Care Med Exp, 2021, 9(1): 34. doi:10.1186/s40635-021-00400-z
doi: 10.1186/s40635-021-00400-z |
2 |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810. doi:10.1001/jama.2016.0287
doi: 10.1001/jama.2016.0287 |
3 |
CHIU C, LEGRAND M. Epidemiology of sepsis and septic shock [J]. Curr Opin Anaesthesiol, 2021, 34(2): 71-76. doi:10.1097/aco.0000000000000958
doi: 10.1097/aco.0000000000000958 |
4 |
DAS U N. Infection, Inflammation, and Immunity in Sepsis [J]. Biomolecules, 2023, 13(9):1332. doi:10.3390/biom13091332
doi: 10.3390/biom13091332 |
5 |
MARTIN M D, BADOVINAC V P, GRIFFITH T S. CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State [J]. Front Immunol, 2020, 11: 1364. doi:10.3389/fimmu.2020.01364
doi: 10.3389/fimmu.2020.01364 |
6 |
BHAT M Y, SOLANKI H S, ADVANI J, et al. Comprehensive network map of interferon gamma signaling [J]. J Cell Commun Signal, 2018, 12(4): 745-751. doi:10.1007/s12079-018-0486-y
doi: 10.1007/s12079-018-0486-y |
7 |
HOYER F F, NAXEROVA K, SCHLOSS M J, et al. Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune Challenge [J]. Immunity, 2019, 51(5): 899-914 e7. doi:10.1016/j.immuni.2019.10.010
doi: 10.1016/j.immuni.2019.10.010 |
8 |
YAO Y, JEYANATHAN M, HADDADI S, et al. Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity [J]. Cell, 2018, 175(6): 1634-1650 e17. doi:10.1016/j.cell.2018.09.042
doi: 10.1016/j.cell.2018.09.042 |
9 |
MARKO L, KVAKAN H, PARK J K, et al. Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage [J]. Hypertension, 2012, 60(6): 1430-1436. doi:10.1161/hypertensionaha.112.199265
doi: 10.1161/hypertensionaha.112.199265 |
10 |
ISHIMITSU T, UEHARA Y, NUMABE A, et al. Interferon gamma attenuates hypertensive renal injury in salt-sensitive Dahl rats [J]. Hypertension, 1992, 19(6 Pt 2): 804-808. doi:10.1161/01.hyp.19.6.804
doi: 10.1161/01.hyp.19.6.804 |
11 |
ZHANG Z, ZHAO L, ZHOU X, et al. Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets [J]. Front Immunol, 2022, 13: 1098725. doi:10.3389/fimmu.2022.1098725
doi: 10.3389/fimmu.2022.1098725 |
12 |
BAO Q, LV R, LEI M. IL-33 attenuates mortality by promoting IFN-gamma production in sepsis [J]. Inflamm Res, 2018, 67(6): 531-538. doi:10.1007/s00011-018-1144-9
doi: 10.1007/s00011-018-1144-9 |
13 |
WANG Y, KONG B B, YANG W P, et al. Immunomodulatory intervention with Gamma interferon in mice with sepsis [J]. Life Sci, 2017, 185: 85-94. doi:10.1016/j.lfs.2017.07.010
doi: 10.1016/j.lfs.2017.07.010 |
14 |
KIM E Y, NER-GAON H, VARON J, et al. Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-gamma in NK cells [J]. J Clin Invest, 2020, 130(6): 3238-3252. doi:10.1172/jci128075
doi: 10.1172/jci128075 |
15 |
CECCONI M, EVANS L, LEVY M, et al. Sepsis and septic shock [J]. Lancet, 2018, 392(10141): 75-87. doi:10.1016/s0140-6736(18)30696-2
doi: 10.1016/s0140-6736(18)30696-2 |
16 |
MADHUR M S, ELIJOVICH F, ALEXANDER M R, et al. Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? [J]. Circ Res, 2021, 128(7): 908-933. doi:10.1161/circresaha.121.318052
doi: 10.1161/circresaha.121.318052 |
17 |
VUCIC J, VUCIC M, STANKOVIC T, et al. Potential role of IFN-gamma and IL-5 in sepsis prediction of preterm neonates [J]. Open Med (Wars), 2021, 16(1): 139-145. doi:10.1515/med-2021-0206
doi: 10.1515/med-2021-0206 |
18 |
NG C T, FONG L Y, ABDULLAH M N H. Interferon-gamma (IFN-gamma): Reviewing its mechanisms and signaling pathways on the regulation of endothelial barrier function [J]. Cytokine, 2023, 166: 156208. doi:10.1016/j.cyto.2023.156208
doi: 10.1016/j.cyto.2023.156208 |
19 |
SATOU R, MIYATA K, GONZALEZ-VILLALOBOS R A, et al. Interferon-gamma biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells [J]. FASEB J, 2012, 26(5): 1821-1830. doi:10.1096/fj.11-195198
doi: 10.1096/fj.11-195198 |
20 |
XIE Y, ZHUANG D, CHEN H, et al. 28-day sepsis mortality prediction model from combined serial interleukin-6, lactate, and procalcitonin measurements: a retrospective cohort study [J]. Eur J Clin Microbiol Infect Dis, 2023, 42(1): 77-85. doi:10.1007/s10096-022-04517-1
doi: 10.1007/s10096-022-04517-1 |
21 |
何天慧,李书文,沈锋,等. 腹部术后合并脓毒症患者死亡风险因素联合预测的价值[J]. 实用医学杂志, 2022,38(7):809-814. doi:10.3969/j.issn.1006-5725.2022.07.007
doi: 10.3969/j.issn.1006-5725.2022.07.007 |
22 |
BARRIOS E L, MAZER M B, MCGONAGILL P W, et al. Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-gamma ELISpot [J]. JCI Insight, 2024, 9(2):e175785. doi:10.1172/jci.insight.175785
doi: 10.1172/jci.insight.175785 |
23 |
BURKE J D, YOUNG H A. IFN-gamma: A cytokine at the right time, is in the right place [J]. Semin Immunol, 2019, 43: 101280. doi:10.1016/j.smim.2019.05.002
doi: 10.1016/j.smim.2019.05.002 |
24 |
HUANG J, SUN R, YANG Y, et al. Splenic T lymphocytes induce the formation of immunosuppressive neutrophils through IFN-gamma in sepsis [J]. Inflamm Res, 2022, 71(1): 81-91. doi:10.1007/s00011-021-01524-4
doi: 10.1007/s00011-021-01524-4 |
25 |
周苏,蒋永泼,戴罕之,等. 脓毒症表型研究新进展[J]. 实用医学杂志, 2022,38(7):804-808. doi:10.3969/j.issn.1006-5725.2022.07.006
doi: 10.3969/j.issn.1006-5725.2022.07.006 |
26 |
KONIG R, KOLTE A, AHLERS O, et al. Use of IFNgamma/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock [J]. Front Immunol, 2021, 12: 607217. doi:10.3389/fimmu.2021.607217
doi: 10.3389/fimmu.2021.607217 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||